Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease.
Nutt
John G
JG
Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, OP32, Portland, OR 97201-3098, USA. storeyl@ohsu.edu
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004298:Dopamine / Q000502:physiology; D020820:Dyskinesias / Q000188:drug therapy / Q000503:physiopathology; D004421:Dystonia / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008134:Long-Term Care; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D000978:Antiparkinson Agents; D007980:Levodopa; D004298:Dopamine